Intellicyt

What Intellicyt does

Intellicyt Corporation is a life sciences instrumentation company founded in 2006 and headquartered in Albuquerque, New Mexico, that develops and markets high-throughput cell and bead-based screening solutions built around flow cytometry. The company's core offering, the iQue HTS Platform (latest generation iQue 5 launched in 2026), combines patented sampling technology with up to 4-laser, 27-channel configurations to process 96-well plates in as little as 5 minutes and 384-well plates in 20 minutes, enabling multiplexed analysis of cell phenotype and function. The platform is supported by the proprietary iQue Forecyt software for acquisition, analysis, and real-time data visualization, complemented by validated reagent kits and design tools including the iQue Cytometry Panel Builder and the iQue Qbeads Assay Builder.

Intellicyt generates revenue through a three-stream model: one-time license sales of iQue cytometer instruments (iQue 5, iQue 3, iQue Screener Plus), recurring consumables and reagent sales (mix-and-read kits, fluorophore-conjugated antibodies, and assay-specific reagents), and professional services (installation, training, technical support, and repair). Distribution runs through enterprise field sales, the Sartorius Shop e-commerce platform with account-verified customer-specific pricing, and a global technical support organization, reflecting an integration with Sartorius's commercial infrastructure. End customers span academic research institutions, biopharmaceutical companies, and contract research organizations, with primary use cases in antibody discovery and characterization, immuno-oncology and T-cell engineering, cytokine profiling, and live-cell analysis research, validated by more than 1,300 peer-reviewed scientific references.

Name

Intellicyt

Legal name

Intellicyt

Website

https://intellicyt.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Intellicyt develops high-throughput flow cytometry screening platforms (iQue HTS) for life sciences research, serving academic and biopharmaceutical customers in antibody discovery, immuno-oncology, T-cell engineering, and cell analysis applications.

Ownership category

akta.pro rank

Product category

High-Throughput Flow Cytometry Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• High-throughput flow cytometry
• Cell screening instruments
• Multiplexed cell analysis
• Antibody discovery assays
• Immuno-oncology research

Headquarters

HQ city

Albuquerque

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. HTS Cytometry Instruments and Software: Sale of iQue® HTS cytometer instruments (iQue 5, iQue 3, iQue Screener Plus) along with proprietary iQue Forecyt® software for acquisition, analysis, and data visualization. Instruments process 96 or 384-well plates and can connect to automation systems for continuous plate loading.
2. Consumables and Reagents: Recurring revenue from proprietary iQue® reagent kits validated for use on the iQue HTS Platform. Includes optimized mix-and-read reagent kits, fluorophore-conjugated antibodies, and assay-specific reagents.
3. Technical Support and Services: Global Technical Support team provides expert installation, training, technical support and repair services to customers worldwide.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Intellicyt develops and markets high-throughput cell and bead-based screening solutions built around the iQue HTS Platform. The offering combines flow cytometry instruments (iQue 5, iQue 3, iQue Screener Plus) with the iQue Forecyt acquisition and analysis software, validated mix-and-read reagent kits, and supporting assay design tools such as the iQue Cytometry Panel Builder and iQue Qbeads Assay Builder. The platform enables live-cell, multiplexed analysis of cell phenotype and function for antibody discovery, T-cell engineering, and immuno-oncology research workflows.

Product overview

The iQue High-Throughput Screening (HTS) Platform by Sartorius is a comprehensive cytometry solution comprising multiple integrated components. The core offering includes the iQue 5 Platform (latest generation instrument with 96/384-well plate processing), the iQue Forecyt Software for acquisition and analysis, and iQue HTS Cytometry Reagents (validated kits). Supporting tools include the iQue Cytometry Panel Builder for panel design and the iQue Qbeads Assay Builder for multiplex assay creation. Previous generation products (iQue 3 and iQue Screener Plus) serve established workflows. The platform enables live-cell, multiplexed analysis of cell phenotype and function supporting applications in antibody discovery, T-cell engineering, and immuno-oncology research.

Differentiator

Problem solved

Functional benefit

Products and services

• iQue 5 High-Throughput Screening (HTS) Platform Advanced high-throughput flow cytometry instrument capable of processing 96-well plates in 5 minutes and 384-well plates in 20 minutes, with up to 4 laser excitation and 27 channel configurations for multiplexed cell analysis. Targets antibody discovery, T-cell engineering, and immuno-oncology research workflows at biopharmaceutical and academic research institutions.
• iQue Forecyt Software Integrated acquisition and analysis software enabling interactive assay development, analysis and multiparameter data visualization with real-time plate-wide updates when gates are adjusted. Used by researchers running multiplexed cell screening workflows on iQue HTS instruments.
• iQue HTS Cytometry Reagents Validated mix-and-read reagent kits optimized for use on the iQue HTS Platform with ready-to-use analysis templates. Supports antibody characterization, cytokine profiling, and cell health analysis applications for biopharmaceutical and academic research customers.
• iQue Cytometry Panel Builder Intelligent web-based tool that helps researchers design optimal multi-color flow cytometry panels tailored to their specific experimental needs. Used by researchers planning multiplexed assays on the iQue HTS Platform.
• iQue Qbeads Assay Builder Easy-to-use web-based tool for designing custom multiplex bead-based assays using iQue Qbeads technology. Supports biomarker analysis applications across antibody discovery and life science research workflows.
• iQue 3 High-Throughput Screening Platform Previous generation high-throughput screening cytometer platform with established workflow capabilities for flow cytometry-based screening applications. Sold to biopharmaceutical and academic research customers running established screening workflows.
• iQue Screener Plus Previous generation screening cytometer variant offering high-throughput flow cytometry analysis capabilities for various screening applications across antibody discovery and life science research workflows.

Quantifiable outcome

• 96 wells processed in as little as 5 minutes; 384 wells in 20 minutes
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• University of CopenhagencoreStrategic or Co-development PartnerAcademic partnership where University of Copenhagen immunology researchers use the iQue HTS Platform for advanced high throughput cytometry to direct drug selection in patients with relapsed Acute Myeloid Leukemia. This collaboration demonstrates the platform's application in translational cancer research.
• University of LiverpoolcoreStrategic or Co-development PartnerAcademic partnership where researchers use HTS cytometry to detect uptake and transport across membranes of small molecules by microbes for small molecule discovery applications. Demonstrates platform utility in microbiology and drug discovery research.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Thermo Fisher Scientific (Attune NxT): Thermo Fisher's Attune NxT acoustic-focused flow cytometer and broader life sciences portfolio compete head-to-head with the iQue HTS platform in research cytometry applications across pharma and academic labs.
• BD Biosciences: BD Biosciences (a segment of Becton Dickinson) is the dominant incumbent in flow cytometry, offering instruments such as FACSChorus, FACSDiscover, and BD Accuri that directly compete with the iQue HTS platform for cell analysis workflows in antibody discovery and immuno-oncology research.
• Beckman Coulter Life Sciences: Beckman Coulter's CytoFLEX and Biomek lines compete with the iQue in high-throughput flow cytometry and screening workflows for academic and biopharma customers, with overlapping capabilities in multiplexed cell analysis.

Direct peers

• Cytek Biosciences: Cytek's Northern Lights spectral flow cytometry platform and Aurora systems are direct flow cytometry peers to the iQue platform, targeting similar high-content, multiplexed cell analysis use cases in immuno-oncology and cell therapy research.
• Bio-Rad Laboratories (ZE5 Cell Analyzer): Bio-Rad's ZE5 and S3e flow cytometry instruments and StarBright reagents compete with the iQue HTS platform for high-throughput, multi-user cell analysis in academic and biopharma research environments.
• Agilent (ACEA Biosciences): Agilent's ACEA Biosciences xCELLigence and NovoCyte flow cytometry platforms compete in real-time cell analysis and high-throughput screening, overlapping with iQue's immuno-oncology and cell function analysis applications.

Others

• Sartorius AG: Sartorius AG is Intellicyt's parent/acquirer and operates the High-Throughput Cytometry product line covering the iQue platform. Although not a peer in a competitive sense, it is the relevant corporate vehicle through which Intellicyt's technology is currently distributed.

Emerging players

• Eurofins DiscoverX: Eurofins DiscoverX provides bead-based and cell-based assay kits and instrumentation services that overlap with iQue's reagent kits and Qbeads multiplex assay workflow for drug discovery screening applications.
• Curiox Biosystems: Curiox provides miniaturized washing and sample preparation automation for bead-based and cell-based assays, complementing and partly competing with the automation integration value proposition of the iQue HTS platform.
• Cytovation (CellRaft AIR): Cytovation's CellRaft technology and AIR system is an emerging single-cell sorting and analysis platform targeting similar antibody discovery and cell engineering use cases where the iQue Qbeads and Forecyt software operate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/intellicyt
• Facebookfacebook.com/intellicyt
• LinkedInlinkedin.com/company/intellicyt-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intellicyt